{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-021345","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2025-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.852619+00:00","generated_at":"2026-05-25T03:35:43.589098+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Silo Pharma receives US patent for stress-induced affective disorder prophylactics","bullets":["USPTO granted Patent No. 12,239,614 for exclusively licensed Columbia University technology.","Patent titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females'.","Patent covers prophylactic treatment for stress-induced affective disorders specifically in females.","License is exclusive from Columbia University; patent application originally filed as 17/954864."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-021345","json":"https://secwatch.observer/filing/0001213900-25-021345.json","markdown":"https://secwatch.observer/filing/0001213900-25-021345.md","text":"https://secwatch.observer/filing/0001213900-25-021345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025021345/0001213900-25-021345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390025021345/ea0233504-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T03:35:43.589098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}